mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.7 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |